Study on the Benefits of a Healthy Diet Plan and Yashtimadhu Hima in Reducing Acidity Symptoms

Efficacy of a structured Pathya Ahara Regimen and Yashtimadhu Hima in the Management of Amlapitta: an open labels comparative study - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101248

Enrollment

Registered

2026-01-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K210- Gastro-esophageal reflux disease with esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Adult patients aged 18 60 years irrespective of sex religion or caste 2 Presence of classical sign and symptoms of amlapitta 3 Duration of Amlapitta symptoms less than 6 months. 4. Patients who provide informed consent and Inclusion in Group A (Structured Pathya Ahara Regimen) or Group B (Yashtimadhu Hima) will be based on the clinical indication and suitability of the intervention for that particular patient as assessed by the investigator

Exclusion criteria

Exclusion criteria: 1. Known case of gastric and duodenal ulcer , gastric carcinoma. 2. Patients testing positive for Helicobacter pylori. 3. Patients with a history of cardiovascular disease or uncontrolled hypertension (systolic equal to and greater than 160 mmHg, diastolic equal to and greater than 100 mmHg despite medication), Renal impairment (Sr. creatinine greater than 1.2 mg/dl), Hepatic impairment (SGOT and SGPT greater than three times the upper limit), uncontrolled diabetes (HbA1c greater than 7.0 percent). 4. Subjects with comorbidities such as Tuberculosis, immunocompromised states such as HIV, history or active malignancy etc. 5. Patient on systemic or oral steroids for more than 1 year. 6. Pregnant women and lactating mother. 7. Patients with congenital anomalies, prior major gastrointestinal surgery. 8. Patients currently under treatment for psychiatric disorders. 9. Patients who have participated in any clinical trial in the past 6 months.

Design outcomes

Primary

Measure	Time frame
Change in the subjective parameters (classical signs and symptoms of Amlapitta example amlodgar,avipaka,aruchi) from baseline.Timepoint: 1 week,2 week,3 week,4 week	—

Secondary

Measure	Time frame
.Diet adherence (80 percent) from compliance charts. 2.Change in Quality of life in patients of amlapitta measured by WHOQOL-BREF scale. 3.Change in the laboratory safety parameters (CBC, LFT, KFT) from baseline. Timepoint: 1 month	—

Countries

India

Contacts

Public ContactDr Sagar Rahangdale

ayurvedic and unani tibbia collegeand hospital ,karol bagh delhi 110005

rajsakshi.sharma@gmail.com9868092250

Outcome results